Literature DB >> 25877763

The biocompatibility of calcium phosphate cements containing alendronate-loaded PLGA microparticles in vitro.

Yu-Hua Li1, Zhen-Dong Wang2, Wei Wang3, Chang-Wei Ding4, Hao-Xuan Zhang1, Jian-Min Li5.   

Abstract

The composite of poly-lactic-co-glycolic acid (PLGA) and calcium phosphate cements (CPC) are currently widely used in bone tissue engineering. However, the properties and biocompatibility of the alendronate-loaded PLGA/CPC (APC) porous scaffolds have not been characterized. APC scaffolds were prepared by a solid/oil/water emulsion solvent evaporation method. The morphology, porosity, and mechanical strength of the scaffolds were characterized. Bone marrow mesenchymal stem cells (BMSCs) from rabbit were cultured, expanded and seeded on the scaffolds, and the cell morphology, adhesion, proliferation, cell cycle and osteogenic differentiation of BMSCs were determined. The results showed that the APC scaffolds had a porosity of 67.43 ± 4.2% and pore size of 213 ± 95 µm. The compressive strength for APC was 5.79 ± 1.21 MPa, which was close to human cancellous bone. The scanning electron microscopy, cell counting kit-8 assay, flow cytometry and ALP activity revealed that the APC scaffolds had osteogenic potential on the BMSCs in vitro and exhibited excellent biocompatibility with engineered bone tissue. APC scaffolds exhibited excellent biocompatibility and osteogenesis potential and can potentially be used for bone tissue engineering.
© 2015 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Bone tissue engineering; alendronate; biocompatibility; mesenchymal stem cells

Mesh:

Substances:

Year:  2015        PMID: 25877763      PMCID: PMC4935296          DOI: 10.1177/1535370215579142

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  34 in total

Review 1.  Nonallograft osteoconductive bone graft substitutes.

Authors:  Robert W Bucholz
Journal:  Clin Orthop Relat Res       Date:  2002-02       Impact factor: 4.176

2.  Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions.

Authors:  Jadranka Kuljanin; Ivana Janković; Jovan Nedeljković; Dusica Prstojević; Valentina Marinković
Journal:  J Pharm Biomed Anal       Date:  2002-06-15       Impact factor: 3.935

3.  Calcium phosphate/poly(D,L-lactic-co-glycolic acid) composite bone substitute materials: evaluation of temporal degradation and bone ingrowth in a rat critical-sized cranial defect.

Authors:  Floor C J van de Watering; Jeroen J J P van den Beucken; X Frank Walboomers; John A Jansen
Journal:  Clin Oral Implants Res       Date:  2011-06-02       Impact factor: 5.977

4.  Preparation and characterization of PLGA microspheres by the electrospraying method for delivering simvastatin for bone regeneration.

Authors:  Subrata Deb Nath; Sora Son; Alexandar Sadiasa; Young Ki Min; Byong Taek Lee
Journal:  Int J Pharm       Date:  2013-01-03       Impact factor: 5.875

Review 5.  Profiling the safety and tolerability of bisphosphonates.

Authors:  Jean-Jacques Body; Ingo Diel; Richard Bell
Journal:  Semin Oncol       Date:  2004-10       Impact factor: 4.929

6.  Physico-chemical-mechanical and in vitro biological properties of calcium phosphate cements with doped amorphous calcium phosphates.

Authors:  Marion Julien; Ibrahim Khairoun; Racquel Z LeGeros; Severine Delplace; Paul Pilet; Pierre Weiss; Guy Daculsi; Jean Michel Bouler; Jerome Guicheux
Journal:  Biomaterials       Date:  2006-11-22       Impact factor: 12.479

7.  Histologic reactions to a newly developed calcium phosphate cement implanted in the periapical and periodontal tissues.

Authors:  C Y Hong; S K Lin; S H Kok; M Y Wong; Y C Hong
Journal:  J Formos Med Assoc       Date:  1990-04       Impact factor: 3.282

8.  Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.

Authors:  Sanjay I Thamake; Sangram L Raut; Zygmunt Gryczynski; Amalendu P Ranjan; Jamboor K Vishwanatha
Journal:  Biomaterials       Date:  2012-07-12       Impact factor: 12.479

9.  Nanocrystalline hydroxyapatite/titania coatings on titanium improves osteoblast adhesion.

Authors:  Michiko Sato; Arash Aslani; Marisa A Sambito; Nader M Kalkhoran; Elliott B Slamovich; Thomas J Webster
Journal:  J Biomed Mater Res A       Date:  2008-01       Impact factor: 4.396

Review 10.  Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis.

Authors:  Serge C L M Cremers; Goonaseelan Pillai; Socrates E Papapoulos
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

View more
  4 in total

Review 1.  Advances in Regenerative Sports Medicine Research.

Authors:  Liren Wang; Jia Jiang; Hai Lin; Tonghe Zhu; Jiangyu Cai; Wei Su; Jiebo Chen; Junjie Xu; Yamin Li; Jing Wang; Kai Zhang; Jinzhong Zhao
Journal:  Front Bioeng Biotechnol       Date:  2022-05-13

2.  Fabrication of a reticular poly(lactide-co-glycolide) cylindrical scaffold for the in vitro development of microvascular networks.

Authors:  Yen-Ting Tung; Cheng-Chung Chang; Jyh-Cherng Ju; Gou-Jen Wang
Journal:  Sci Technol Adv Mater       Date:  2017-03-01       Impact factor: 8.090

3.  The 3D-Printed PLGA Scaffolds Loaded with Bone Marrow-Derived Mesenchymal Stem Cells Augment the Healing of Rotator Cuff Repair in the Rabbits.

Authors:  Peng Chen; Lei Cui; Sai Chuen Fu; Li Shen; Wentao Zhang; Tian You; Tim-Yun Ong; Yang Liu; Shu-Hang Yung; Changqing Jiang
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

4.  Alendronate release from calcium phosphate cement for bone regeneration in osteoporotic conditions.

Authors:  Claire I A van Houdt; Paulo R Gabbai-Armelin; Paula M Lopez-Perez; Dietmar J O Ulrich; John A Jansen; Ana Claudia M Renno; Jeroen J J P van den Beucken
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.